News

Wednesday January 27, 2021

27 Jan 2021 – Destiny Pharma welcomes Matt Hancock’s statement saying G7 wil...

Destiny Pharma welcomes Matt Hancock’s attention to antimicrobial resistance within his speech on the UK taking presidency of the G7. Mr Hancock states “This is a matter of driving forward […]

Thursday January 21, 2021

21 Jan 2021 – Destiny Pharma Investor Presentation

Destiny Pharma plc (“Destiny Pharma” or the “Company”)  Investor Presentation Brighton, United Kingdom – 21st January 2021 – Destiny Pharma plc (AIM: DEST, “the Company”) a clinical stage innovative biotechnology […]

Wednesday January 6, 2021

06 Jan 2021 – Destiny Pharma appoints Stephanie Bewick as Chief Business Officer

Destiny Pharma plc (“Destiny Pharma” or “the Company”) Destiny Pharma Appoints Stephanie Bewick as Chief Business Officer Brighton, United Kingdom – 6th January 2021 – Destiny Pharma plc (AIM: DEST), […]

Tuesday January 5, 2021

05 Jan 2021 – Phase 2b trial of XF-73 completes recruitment

Destiny Pharma plc (“Destiny Pharma” or “the Company”) Phase 2b clinical trial of XF-73 completes patient recruitment   Results expected in Q1 2021 Brighton, United Kingdom – 5th January 2021 […]